Telangana, India

Raman Kumar Kalakuntla

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Raman Kumar Kalakuntla

Introduction

Raman Kumar Kalakuntla is a notable inventor based in Telangana, India. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of cancer and infectious diseases. With a total of 2 patents, his work focuses on innovative methods that target specific enzymes to enhance treatment efficacy.

Latest Patents

Kalakuntla's latest patents include groundbreaking work on inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1). These patents detail compounds and methods for their preparation and use as therapeutic or prophylactic agents. His research aims to provide new avenues for treating cancer, bacterial, or viral diseases by specifically targeting ENPP1.

Career Highlights

Raman Kumar Kalakuntla is currently associated with Stingray Therapeutics, Inc., where he continues to advance his research and development efforts. His innovative approach has positioned him as a key figure in the therapeutic landscape, particularly in the context of enzyme inhibitors.

Collaborations

Some of his notable coworkers include Srinivas Rao Kasibhatla and Alexis Weston, who contribute to the collaborative efforts in their research initiatives.

Conclusion

Raman Kumar Kalakuntla's work exemplifies the spirit of innovation in the field of therapeutic development. His patents and ongoing research hold promise for significant advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…